Gara Jalqabaatti › Myelofibrosis › Tennessee › Nashville
Qorannoo klinikaalii Myelofibrosis Nashville, TN keessatti
Qorannoo 9 Myelofibrosis f Nashville fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Namoota walitti qabaa jiraSadarkaa 1/2
- Tri-Star Centennial Medical Center, Nashville
- Vanderbilt University, Nashville
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Namoota walitti qabaa jiraSadarkaa 3
- Vanderbilt-Ingram Cancer Center (VICC)-Nashville, Nashville
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
- Tennessee Oncology, PLLC - Investigational Drug Services, Nashville
- Tristar BMT, Nashville
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Namoota walitti qabaa jiraSadarkaa 2
- Vanderbilt University/Ingram Cancer Center, Nashville
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
- Tristar Bmt/Tcto, Nashville
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
Namoota walitti qabaa jiraSadarkaa 2
- GSK Investigational Site, Nashville
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
- Vanderbilt University Medical Center, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Nashville
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Namoota walitti qabaa jiraSadarkaa 3
- Tennessee Oncology, Nashville
- Vanderbilt University Medical Center, Nashville
Qorannoo Myelofibrosis magaalota biroo keessatti
- Houston, TXQorannoo 19
- New York City, NYQorannoo 18
- Boston, MAQorannoo 12
- Durham, NCQorannoo 12
- Columbus, OHQorannoo 11
- Seattle, WAQorannoo 11
- Salt Lake City, UTQorannoo 10
- Miami, FLQorannoo 10
- Atlanta, GAQorannoo 9
- Baldwin Park, CAQorannoo 9
- Tampa, FLQorannoo 9
- Cleveland, OHQorannoo 9
Qorannoo biroo Nashville keessatti
- Kansara Qara'a Non-Small CellQorannoo 97
- Saree OljooQorannoo 81
- Kansara MetastatikiiQorannoo 70
- Kansarii ColorectalQorannoo 69
- Saree (Gosoota Hunda)Qorannoo 65
- Kansarii OvariiQorannoo 49
- Kansarii ProstateQorannoo 43
- Dhibee QaraQorannoo 40
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 39
- Kansarii PancreasQorannoo 39
- Kansa EndometiriyaaliiQorannoo 38
- MelanomaQorannoo 33
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.